B. Riley Wealth Advisors’s Sonoma Pharmaceuticals, Inc. Warrants SNOAW Stock Holding History

B. Riley Wealth Advisors’s Portfolio SNOAW Stock Details SNOAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-17,500	Closed	-$10K	–	570
2017 Q1	$10K	Sell	17,500 -1,000	-5%	-$505	﹤0.01%	515
2016 Q4	$8K	Buy	+18,500	New	+$6.78K	﹤0.01%	532

Other funds holding SNOAW

MIG

Mariner Investment Group Harrison, New York $463M AUM 13.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

B. Riley Wealth Advisors's SNOAW Position: Q2 2017 in Review

B. Riley Wealth Advisors sold out of Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) in Q2 2017, closing a stake of 17,500 shares — an estimated $10K sold.

B. Riley Wealth Advisors first reported a position in SNOAW in Q4 2016 and held it in 2 quarters. The position peaked at $10K in Q1 2017. 3 funds tracked by Wall St. Rank hold SNOAW as of Q2 2017.

B. Riley Wealth Advisors reported no remaining Sonoma Pharmaceuticals, Inc. Warrants position as of Q2 2017 after selling out during the quarter.
B. Riley Wealth Advisors sold 17,500 Sonoma Pharmaceuticals, Inc. Warrants shares in Q2 2017, an estimated $10K.
B. Riley Wealth Advisors first reported a position in Sonoma Pharmaceuticals, Inc. Warrants in Q4 2016 and held it in 2 quarters.
B. Riley Wealth Advisors's Sonoma Pharmaceuticals, Inc. Warrants position peaked at $10K in Q1 2017.
3 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals, Inc. Warrants as of Q2 2017.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2017, filed 15 Aug 2017.